


Dr. Olufunmilayo Olopade, MD
Dr. Olufunmilayo Olopade, MD is a medical oncologist in Chicago, IL and has over 40 years of experience in the medical field. She graduated from University of Ibadan School of Medicine in 1980. She is affiliated with The University of Chicago Medical Center.
Practice
5841 S Maryland Ave Chicago, IL 60637Make an Appointment
Compare with other Medical Oncologists
Compare Dr. Olopade with our nearby Medical Oncologists at Mayo.
Experience Check
Search for experience in a specific area
Dr. Olopade's Reviews
Likelihood to recommend Dr. Olopade
5 star | 0% | 0% |
4 star | 0% | 0% |
3 star | 0% | 0% |
2 star | 0% | 0% |
1 star | 100% | 100% |
Your trust is our top concern.
We strive to keep reviews honest, trustworthy, and fair.Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Leave a review
How was your experience with Dr. Olopade?Overall Patient Satisfaction
Likelihood of recommending Dr. Olopade to family and friends is 1 out of 5
About Me
biography
Dr. Olufunmilayo Olopade, MD is a medical oncologist in Chicago, IL and has over 40 years of experience in the medical field. She graduated from University of Ibadan School of Medicine in 1980. She is affiliated with The University of Chicago Medical Center.Medical Oncology
Internal Medicine
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University Of Ibadan School Of Medicine
Medical School, 1980
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkLongitudinal follow-up after telephone disclosure in the randomized COGENT Study, 2020-05-07
A compact VEGF signature associated with distant metastases and poor outcomes, 2009-03-16
Subtype-specific expression ofMELKis partly due to copy number alterations in breast cancer, 2022-06-24
The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions, 2023-02-18
Genetic Variation inIGF2andHTRA1and Breast Cancer Risk amongBRCA1andBRCA2Carriers, 2011-06-27
Identification of six new susceptibility loci for invasive epithelial ovarian cancer, 2015-01-12
Ancestry-Shift Refinement Mapping of theC6orf97-ESR1Breast Cancer Susceptibility Locus, 2010-07-22
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer, 2016-07-07
Oestrogen receptor status and survival in women with BRCA2-associated breast cancer, 2019-02-06
ß-catenin regulatesc-MycandCDKN1Aexpression in breast cancer cells, 2015-02-08
Novel germlinePALB2truncating mutations in African-American breast cancer patients, 2011-08-26
The use of allelic imbalance to ascertaincis-regulation for humanUGT2B7 in vivo, 2013-06-06
Shared heritability and functional enrichment across six solid cancers, 2019-01-25
Association analysis identifies 65 new breast cancer risk loci, 2017-10-23
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer, 2015-02-24
Modification ofBRCA1-Associated Breast and Ovarian Cancer Risk byBRCA1Interacting Genes, 2011-07-28
Benign breast disease and breast cancer risk in African women: A case-control study, 2023-09-01
No clinical utility ofKRASvariant rs61764370 for ovarian or breast cancer, 2015-05-02
The Breast-Thyroid Cancer Link: A Systematic Review and Meta-Analysis, 2015-11-30
A genome-wide association study of breast cancer in women of African ancestry, 2012-08-25
Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry, 2017-04-04
Mutations in Context: Implications ofBRCATesting in Diverse Populations, 2018-05-18
Racial differences in a high-risk colorectal cancer referral population: a single-center experience, 2011-03-10
LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications, 2018-10-22
A functionally significant SNP in TP53 and breast cancer risk in African-American women, 2017-02-27
Glucocorticoid receptor expression in breast cancer associates with older patient age, 2008-07-31
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status, 2020-03-01
Clinical Significance of KISS1 Protein Expression for Brain Invasion and Metastasis, 2011-09-16
Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer, 2016-11-02
Implementing oncology clinical trials in Nigeria: a model for capacity building, 2020-08-03
Differences in somaticTP53mutation type in breast tumors by race and receptor status, 2022-03-14
Performance of Lynch Syndrome Predictive Models in a Multi-center US Referral Population, 2011-07-12
GermlineHOXB13mutations p.G84E and p.R217C do not confer an increased breast cancer risk, 2020-06-16
Development of a Breast Cancer Risk Prediction Model for Women in Nigeria, 2018-04-20
A metabolome-wide case-control study of african american breast cancer patients, 2023-02-23
Population-dependent Intron Retention and DNA Methylation in Breast Cancer, 2018-01-12
Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma, 2012-12-29
Translational Integrity and Continuity: Personalized Biomedical Data Integration, 2008-08-12
Two truncating variants inFANCCand breast cancer risk, 2019-08-29
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes, 2020-01-07
Proceedings from the 9thannual conference on the science of dissemination and implementation Washington, DC, USA. 14-15 December 2016, 2017-04-20
Traditional medicine usage among adult women in Ibadan, Nigeria: a cross-sectional study, 2020-03-20
The molecular portraits of breast tumors are conserved across microarray platforms, 2006-04-27
Feasibility of genetic testing for cancer risk assessment programme in Nigeria, 2021-09-07
rs2981582 is associated withFGFR2expression in normal breast, 2009-12-03
Tumor Genome Analysis Includes Germline Genome: Are We Ready for Surprises?, 2014-08-14
Focus on Breast Cancer
Insurance Check
Search for your insurance carrier and choose your plan type
Locations
Practice
Practice
Affiliated Hospitals
- Recipient of 30
hospital awardsView all awardsAmerica's 250 Best Hospitals Award™ (2025, 2024, 2023)
Top 5% in the nation for consistently delivering clinical quality
View all patient feedbackHow patients felt about the care they received at this hospital.
86%Patients said they were given information about recovering at home2% higher than the national average
80%Patients said that doctors always listened to them and explained things well4% higher than the national average
Compare with other Medical Oncologists
Compare Dr. Olopade with our nearby Medical Oncologists at Mayo.